Allianz Asset Management Gmb H I Mab Transaction History

Allianz Asset Management Gmb H

  • $69.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$44.38 - $63.97 $1.73 Million - $2.49 Million
-38,895 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$32.94 - $47.15 $625,365 - $895,142
18,985 Added 95.35%
38,895 $1.83 Million
Q2 2020

Aug 14, 2020
BUY
$13.0 - $31.0 $258,830 - $617,210
19,910 New
19,910 $596,000

Others Institutions Holding IMAB

# of Institutions
36
Shares Held
15.5M
Call Options Held
56.4K
Put Options Held
5.8K
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $74.8M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email